01515nam 2200409 a 450 991069559270332120070111101528.0(CKB)5470000002370839(OCoLC)77593544(EXLCZ)99547000000237083920070111d2006 ua 0engurmn|---|||||txtrdacontentcrdamediacrrdacarrierNew drug development[electronic resource] science, business, regulatory, and intellectual property issues cited as hampering drug development efforts : report to congressional requesters[Washington, D.C.] :U.S. Government Accountability Office,[2006]ii, 47 pages digital, PDF fileTitle from title screen (viewed on Jan. 10, 2007)."November 2006."Paper version available from: U.S. Government Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548."GAO-07-49."Includes bibliographical references.New drug development Pharmaceutical industryResearchUnited StatesDrug developmentUnited StatesDrug approvalUnited StatesPharmaceutical industryResearchDrug developmentDrug approvalGPOGPOBOOK9910695592703321New drug development3545730UNINA